Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide-induced toxic pustuloderma

A Darvay1, T Basarab, R Russell-Jones

  • 1Department of Dermatology, Ealing Hospital, UK.

Clinical and Experimental Dermatology
|May 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A brighter future for melanoma.

The British journal of dermatology·2019
Same author

The value of sentinel lymph node biopsy in Merkel cell carcinoma.

The British journal of dermatology·2016
Same author

When will selective lymphadenectomy become standard of care in melanoma?

International journal of clinical practice·2012
Same author

A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms.

The British journal of dermatology·2010
Same author

Predictors of patient satisfaction with initial diagnosis and management of malignant melanoma.

Clinical and experimental dermatology·2009
Same author

Bexarotene therapy for mycosis fungoides and Sézary syndrome.

The British journal of dermatology·2009
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

A rare side effect of thalidomide, toxic pustuloderma, is reported in a patient with severe nodular prurigo. This case highlights the importance of recognizing this adverse reaction with increasing thalidomide use in dermatology.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Thalidomide is increasingly utilized for various dermatological conditions.
  • Severe nodular prurigo is a debilitating skin disorder.

Observation:

  • A patient with severe nodular prurigo developed toxic pustuloderma.
  • This adverse reaction occurred secondary to thalidomide treatment.

Findings:

  • This is the first reported case of toxic pustuloderma secondary to thalidomide in a patient with nodular prurigo.
  • The findings suggest a potential rare side effect of thalidomide.

Implications:

  • Clinicians should be aware of this rare but serious side effect.
  • Recognition of this adverse event is crucial for patient safety during thalidomide therapy.

Related Experiment Videos